Page last updated: 2024-10-22

amsacrine and Lymphoma, Large-Cell, Anaplastic

amsacrine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fanin, R1
Silvestri, F1
Geromin, A1
Cerno, M1
Infanti, L1
Zaja, F1
Barillari, G1
Savignano, C1
Rinaldi, C1
Damiani, D1
Baccarani, M1

Other Studies

1 other study available for amsacrine and Lymphoma, Large-Cell, Anaplastic

ArticleYear
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
    Leukemia & lymphoma, 1997, Volume: 24, Issue:3-4

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp

1997